Cleared Traditional

CALFORMA CALCIUM SULFATE BONE GRAFT BARRIER, MODEL 0.5G/1.0G (K042730) - FDA 510(k) Clearance

Class II Dental device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K042730 · Lifecorebiomedical · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2005
Decision
136d
Days
Class 2
Risk

K042730 is an FDA 510(k) clearance for the CALFORMA CALCIUM SULFATE BONE GRAFT BARRIER, MODEL 0.5G/1.0G. Classified as Bone Grafting Material, Synthetic (product code LYC), Class II - Special Controls.

Submitted by Lifecorebiomedical (Chaska, US). The FDA issued a Cleared decision on February 14, 2005 after a review of 136 days - within the typical 510(k) review window.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3930 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Lifecorebiomedical devices

Submission Details

510(k) Number K042730 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 01, 2004
Decision Date February 14, 2005
Days to Decision 136 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
9d slower than avg
Panel avg: 127d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LYC Bone Grafting Material, Synthetic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3930
Definition A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Peers - LYC Bone Grafting Material, Synthetic

All 229
Devices cleared under the same product code (LYC) and FDA review panel - the closest regulatory comparables to K042730.
Bonalive Maxillofacial
K253883 · Bonalive , Ltd. · May 2026
BONTREE PLUS
K251818 · Hudens Bio Co., Ltd. · Mar 2026
FG Bone Graft M
K244006 · Full Golden Biotech Co., Ltd. · Sep 2025
FG Bone Graft B
K243745 · Full Golden Biotech Corporation · Aug 2025
Synthetic Bone Graft Particulate
K241186 · Shenzhen Dazhou Medical Technology Co., Ltd. · Feb 2025
CMFlexTM
K213260 · Dimension Inx Corp. · Dec 2022